Biological abnormalities of peripheral A2A receptors in a large representation of polyglutamine disorders and Huntington's disease stages
- 31 July 2007
- journal article
- Published by Elsevier BV in Neurobiology of Disease
- Vol. 27 (1), 36-43
- https://doi.org/10.1016/j.nbd.2007.03.011
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Effect of Lipid Rafts on Cb2 Receptor Signaling and 2-Arachidonoyl-Glycerol Metabolism in Human Immune CellsPublished by The American Association of Immunologists ,2006
- Early and transient alteration of adenosine A2A receptor signaling in a mouse model of Huntington diseaseNeurobiology of Disease, 2006
- The platelet maximum number of A2A-receptor binding sites (Bmax) linearly correlates with age at onset and CAG repeat expansion in Huntington's disease patients with predominant choreaNeuroscience Letters, 2006
- Genome-wide expression profiling of human blood reveals biomarkers for Huntington's diseaseProceedings of the National Academy of Sciences of the United States of America, 2005
- Lipid Rafts Control Signaling of Type-1 Cannabinoid Receptors in Neuronal CellsJournal of Biological Chemistry, 2005
- Rate of functional decline in Huntington’s diseaseNeurology, 2000
- Two-photon fluorescence microscopy of laurdan generalized polarization domains in model and natural membranesBiophysical Journal, 1997
- Role of Lipid Peroxidation in Electroporation-Induced Cell PermeabilityBiochemical and Biophysical Research Communications, 1995
- Guidelines for the molecular genetics predictive test in Huntington's diseaseNeurology, 1994
- Huntington diseaseNeurology, 1981